-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple…
TUCSON, Ariz., Jan. 13, 2022 (GLOBE NEWSWIRE) -- In response to calls for doubling down on costly failed public health…
Veranome expands its spatial omics intellectual property portfolio into unbiased in-situ sequencing to address a broader set of applications with…
A return to growth in direct sales of Safe OrthopaedicsSafe Medical annual sales up 50% Cash position of €0.9M and…
This Study performs unique rapid on-site measurement using patient whole blood and positions Company to move forward with multiple initiativesACTON,…
myAir Launches AI System For Natural Stress Management myAir Insights combines functional, plant-based nutrition with data-driven technology to create a…
Promising New Approach for a Fatal Neurological DisorderGUILFORD, Conn., Jan. 13, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage…
SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today Sorrento Therapeutics Mexico (“Sorrento…
Data confirm strong anticancer activity of two lead compounds in CT-01 programResults support advancement of CT-01 compounds towards IND expected…
-- DAYBREAK is the most comprehensive Phase 2 trial ever initiated in rare genetic diseases of obesity ---- DAYBREAK is…